These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 22197537

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).
    Castanheira M, Watters AA, Mendes RE, Farrell DJ, Jones RN.
    J Antimicrob Chemother; 2010 Jul; 65(7):1353-8. PubMed ID: 20430787
    [Abstract] [Full Text] [Related]

  • 3. Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.
    Chen HJ, Hung WC, Tseng SP, Tsai JC, Hsueh PR, Teng LJ.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4985-91. PubMed ID: 20855746
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis.
    McLaws F, Chopra I, O'Neill AJ.
    J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence of fusB in Staphylococcus aureus clinical isolates.
    Huang J, Ye M, Ding H, Guo Q, Ding B, Wang M.
    J Med Microbiol; 2013 Aug; 62(Pt 8):1199-1203. PubMed ID: 23639984
    [Abstract] [Full Text] [Related]

  • 12. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
    Rijnders MI, Wolffs PF, Hopstaken RM, den Heyer M, Bruggeman CA, Stobberingh EE.
    J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
    [Abstract] [Full Text] [Related]

  • 13. Genomic analysis reveals different mechanisms of fusidic acid resistance in Staphylococcus aureus from Danish atopic dermatitis patients.
    Edslev SM, Clausen ML, Agner T, Stegger M, Andersen PS.
    J Antimicrob Chemother; 2018 Apr 01; 73(4):856-861. PubMed ID: 29253168
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.
    Besier S, Ludwig A, Brade V, Wichelhaus TA.
    Antimicrob Agents Chemother; 2005 Apr 01; 49(4):1426-31. PubMed ID: 15793122
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.
    Chen W, He C, Yang H, Shu W, Cui Z, Tang R, Zhang C, Liu Q.
    BMC Microbiol; 2020 Jun 29; 20(1):183. PubMed ID: 32600253
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.